Relafen 750, pharmacologically known as naproxen, represents a fascinating illustration within the molecular pharmacy area. Its mechanism of action copyrights on inhibiting cyclooxygenase proteins, specifically COX-1 and COX-2, thereby lessening the generation of prostaglandins, which are essential mediators of pain and heat. This specific inhibiti